Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/57469
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKizmaz, Erhan-
dc.contributor.authorTelli, Atalay, O.-
dc.contributor.authorÇetin, N.-
dc.contributor.authorUğurlu, E.-
dc.date.accessioned2024-06-29T13:49:56Z-
dc.date.available2024-06-29T13:49:56Z-
dc.date.issued2024-
dc.identifier.issn0954-6111-
dc.identifier.urihttps://doi.org/10.1016/j.rmed.2024.107696-
dc.identifier.urihttps://hdl.handle.net/11499/57469-
dc.description.abstractBackground: Pulmonary rehabilitation (PR) is an effective treatment method for chronic obstructive pulmonary disease (COPD). However, individuals with chronic diseases that require lifelong treatment and experience exacerbations need motivational methods. Objectives: The aim of this study was to examine the effects of virtual reality on symptoms, daily living activity, functional capacity, anxiety and depression levels in COPD exacerbation. Methods: Fifty patients hospitalized for COPD exacerbation were included in the study. They were randomly assigned to two groups. Twenty-five patients participated in a traditional PR (once-daily until discharge), including pedaling exercises. The second/25 patients followed the same protocol but experienced cycling simulation in the forest via virtual reality (VR + PR). All patients were evaluated using 1-minute/Sit-to-Stand test (STST), modified-Medical Research Council (mMRC) scale, COPD Assessment test (CAT), Hospital Anxiety and Depression Scale (HADS), and London Chest Activities of Daily Living (LCADL) before and after the treatment. Results: The STST showed an increase in both groups post-treatment, notably higher in the VR + PR (p = 0.037). Dyspnea levels and CAT scores decreased in all patients, but the decrease was greater in the PR + VR group for both parameters (p = 0.062, p = 0.003; respectively). Both groups experienced a reduction in the HADS scores compared to the pre-treatment, with a more significant decrease in depression and the total score in the VR + PR (p < 0.05). LCADL's sub-parameters and total score, excluding household, decreased in both groups after treatment (p < 0.05). The improvement was more substantial in the VR + PR. Conclusions: Virtual reality provides benefits in the management of COPD exacerbations and can be used safely. Clinical trial registiration: Registered at clinicaltrials.gov, registration ID: NCT05687396, URL: www.clinicaltrials.gov. © 2024 Elsevier Ltden_US
dc.description.sponsorship2022SABE006en_US
dc.language.isoenen_US
dc.publisherW.B. Saunders Ltden_US
dc.relation.ispartofRespiratory Medicineen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCOPDen_US
dc.subjectExacerbationen_US
dc.subjectPulmonary rehabilitationen_US
dc.subjectVirtual realityen_US
dc.subjectC reactive proteinen_US
dc.subjectadulten_US
dc.subjectanxietyen_US
dc.subjectanxiety disorderen_US
dc.subjectArticleen_US
dc.subjectchronic obstructive lung diseaseen_US
dc.subjectcontrolled studyen_US
dc.subjectCOPD assessment testen_US
dc.subjectcyclingen_US
dc.subjectdaily life activityen_US
dc.subjectdepressionen_US
dc.subjectdisease exacerbationen_US
dc.subjectdyspneaen_US
dc.subjectexerciseen_US
dc.subjectfemaleen_US
dc.subjectforced expiratory volumeen_US
dc.subjectforced vital capacityen_US
dc.subjectfunctional statusen_US
dc.subjectHospital Anxiety and Depression Scaleen_US
dc.subjecthospitalizationen_US
dc.subjecthumanen_US
dc.subjectleisureen_US
dc.subjectmajor clinical studyen_US
dc.subjectmaleen_US
dc.subjectmiddle ageden_US
dc.subjectneurorehabilitationen_US
dc.subjectprotein blood levelen_US
dc.subjectpulmonary rehabilitationen_US
dc.subjectrandomized controlled trialen_US
dc.subjectself careen_US
dc.subjectsingle blind procedureen_US
dc.subjectsit-to-stand testen_US
dc.subjectvirtual realityen_US
dc.subjectageden_US
dc.subjectanxietyen_US
dc.subjectdisease exacerbationen_US
dc.subjectetiologyen_US
dc.subjectkinesiotherapyen_US
dc.subjectpathophysiologyen_US
dc.subjectproceduresen_US
dc.subjectpsychologyen_US
dc.subjectrehabilitationen_US
dc.subjecttherapyen_US
dc.subjecttreatment outcomeen_US
dc.subjectActivities of Daily Livingen_US
dc.subjectAgeden_US
dc.subjectAnxietyen_US
dc.subjectDepressionen_US
dc.subjectDisease Progressionen_US
dc.subjectDyspneaen_US
dc.subjectExercise Therapyen_US
dc.subjectFemaleen_US
dc.subjectHumansen_US
dc.subjectMaleen_US
dc.subjectMiddle Ageden_US
dc.subjectPulmonary Disease, Chronic Obstructiveen_US
dc.subjectTreatment Outcomeen_US
dc.subjectVirtual Realityen_US
dc.titleVirtual reality for COPD exacerbation: A randomized controlled trialen_US
dc.typeArticleen_US
dc.identifier.volume230en_US
dc.departmentPamukkale Universityen_US
dc.identifier.doi10.1016/j.rmed.2024.107696-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid57921518800-
dc.authorscopusid57190847961-
dc.authorscopusid57219858020-
dc.authorscopusid56158762100-
dc.identifier.pmid38857811en_US
dc.identifier.scopus2-s2.0-85195458063en_US
dc.identifier.wosWOS:001256434700001en_US
dc.institutionauthor-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.openairetypeArticle-
crisitem.author.dept16.01. Physiotherapy and Rehabilitation-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:Fizyoterapi ve Rehabilitasyon Fakültesi
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

Page view(s)

38
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.